Methylene Blue Drug Interaction Checker
The most dangerous methylene blue interactions are with serotonergic drugs. Methylene blue is a potent monoamine oxidase inhibitor (MAOI) (Ramsay RR et al., 2007, British Journal of Pharmacology), and combining it with antidepressants (SSRIs, SNRIs, MAOIs), certain painkillers, or stimulants can trigger serotonin syndrome — the FDA-approved label carries a boxed warning that this can be serious or fatal (FDA ProvayBlue label, 2024). Use the checker below to see the risk level for a specific medication.
Important: This checker is an educational tool, not medical advice and not a substitute for a pharmacist or physician. It covers common, well-documented interactions but is not exhaustive. Never start, stop, or combine medications based on this tool alone. If you take any prescription medication, confirm with a healthcare professional before using methylene blue.
Don't see your medication? That does not mean it is safe — ask your pharmacist. Methylene blue also causes dangerous red-blood-cell breakdown in people with G6PD deficiency, and should be avoided in pregnancy and breastfeeding (FDA ProvayBlue label, 2024; Cappellini MD & Fiorelli G, 2008, The Lancet).
How to read the results
- ⛔ Do not combine — a serotonergic or otherwise high-risk interaction. Requires medical supervision; usually avoided entirely.
- ⚠️ Caution — potential for added risk (blood pressure, additive effects). Discuss with a professional first.
- 🩸 Special condition — a health condition (like G6PD deficiency) that makes methylene blue itself unsafe.
- ◦ Not a major documented interaction — not on the well-known interaction list, but this tool is not exhaustive; still confirm with a pharmacist.
Why serotonergic drugs are the core danger
Methylene blue inhibits monoamine oxidase, the enzyme that breaks down serotonin. Drugs that raise serotonin — SSRIs, SNRIs, MAOIs, tricyclics, some opioids like tramadol, triptans, and even supplements like St John's Wort and 5-HTP — can push serotonin dangerously high when that enzyme is blocked. The result can be serotonin syndrome, which the FDA cited in its warning about methylene blue. The label lists SSRIs, SNRIs, MAOIs, bupropion, buspirone, clomipramine, mirtazapine, linezolid, opioids and dextromethorphan among the drugs to avoid (FDA ProvayBlue label, 2024). Read the full methylene blue drug interactions guide and our safety overview for detail, and see the specific cases of Adderall and alcohol.
Frequently Asked Questions
Is this checker a substitute for my doctor? No. It is educational and not exhaustive. Your pharmacist has your full medication list and is the right person to confirm any combination.
What if my medication isn't listed? Absence from this tool does not mean a combination is safe. Ask a professional, especially if you take multiple medications.
I take an antidepressant — can I use methylene blue? Most antidepressants are serotonergic, which is the highest-risk category. Do not combine without your prescriber's guidance.
Where can I buy tested methylene blue? If cleared by your professional, use a USP pharmaceutical-grade methylene blue with a certificate of analysis.
Sources
- U.S. Food and Drug Administration. PROVAYBLUE (methylene blue) injection prescribing information, revised 02/2024, including the boxed warning on serotonin syndrome. accessdata.fda.gov.
- Ramsay RR, Dunford C, Gillman PK. Methylene blue and serotonin toxicity: inhibition of monoamine oxidase A (MAO A) confirms a theoretical prediction. British Journal of Pharmacology. 2007. PMID 17721552.
- Cappellini MD, Fiorelli G. Glucose-6-phosphate dehydrogenase deficiency. The Lancet. 2008. PMID 18177777.
These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. This tool is general information, not medical advice.
Share
